Push the boundaries of what’s possible in sustained drug delivery with the VitalDose® EVA drug delivery platform from Celanese. This enabling technology platform provides long-acting controlled release through implant and insert dosage forms, delivering small molecules, biologics, and RNA for ophthalmology, oncology, women's health, rare diseases and conditions of the central nervous system. Work with Celanese experts in the Celanese Development & Feasibility Lab for customized support and services to enable innovative drug delivery within your desired release profile.
Visit Celanese booth to speak with one of our experts about your application.